OpGen Inc (OTCPK:OPGN)

$ 0.6375 0.018125 (2.93%) Market Cap: 6.42 Mil Enterprise Value: 6.84 Mil PE Ratio: 0 PB Ratio: 2.13 GF Score: 40/100

Q2 2023 OpGen Inc Earnings Call Transcript
Aug 10, 2023

$3.38 (-23.42%)

Earnings
Q1 2023 OpGen Inc Earnings Call Transcript
May 15, 2023

$7 (-6.91%)

Earnings
Q4 2022 OpGen Inc Earnings Call Transcript
Mar 29, 2023

$13.6 (-6.85%)

Earnings
Q3 2022 OpGen Inc Earnings Call Transcript
Nov 10, 2022

$37 (+4.17%)

Earnings
Q2 2022 OpGen Inc Earnings Call Transcript
Aug 11, 2022

$126 (+5.00%)

Earnings
Q1 2022 OpGen Inc Earnings Call Transcript
May 12, 2022

$71.52 (+12.52%)

Earnings
Q4 2021 OpGen Inc Earnings Call Transcript
Mar 29, 2022

$170 (+10.68%)

Earnings
Q3 2021 OpGen Inc Earnings Call Transcript
Nov 11, 2021

$340

Earnings
Q2 2021 OpGen Inc Earnings Call Transcript
Aug 12, 2021

$508 (-7.30%)

Earnings
Q1 2021 OpGen Inc Earnings Call Transcript
May 13, 2021

$398 (-11.56%)

Earnings
Q4 2020 OpGen Inc Earnings Call Transcript
Mar 25, 2021

$540 (-0.74%)

Earnings
Q3 2020 OpGen Inc Earnings Call Transcript
Nov 11, 2020

$458 (+7.01%)

Earnings
Q2 2020 OpGen Inc Earnings Call Transcript
Aug 12, 2020

$522 (+1.95%)

Earnings
Q1 2020 OpGen Inc Earnings Call Transcript
May 07, 2020

$448 (-0.44%)

Earnings
Q4 2019 OpGen Inc Earnings Call Transcript
Mar 24, 2020

$598 (-4.47%)

Earnings
Q3 2019 OpGen Inc Earnings Call Transcript
Nov 06, 2019

$264 (+3.94%)

Earnings
OpGen Inc and Curetis NV Enter Into Definitive Agreement to Combine Businesses - M&A Call Transcript
Sep 04, 2019
Q2 2019 OpGen Inc Earnings Call Transcript
Aug 07, 2019

$1300 (+4.57%)

Earnings
Q1 2019 OpGen Inc Earnings Call Transcript
May 14, 2019

$1720 (-11.52%)

Earnings
Q4 2018 OpGen Inc Earnings Call Transcript
Feb 26, 2019

$5760 (-4.00%)

Earnings

Q3 2022 OpGen Inc Earnings Call Transcript

Nov 10, 2022 / 09:30PM GMT

Release Date Price: $37 (+4.17%)

Transcript 10-Q8-K

Operator

Welcome to the OpGen Third Quarter 2022 Earnings Call and Business Update. Today, OpGen management will provide an update on the company's current business and outlook for the future. Following OpGen's prepared remarks, there will be a live Q&A session. As a reminder, this conference call is being recorded today, November 10, 2022. (Operator Instructions)

At this time, we will turn the call over to Alyssa Factor, OpGen's IR representatives, to provide opening statements.

Alyssa Factor;Edison Group;Investor Relations Associate

Good afternoon, everyone, and thank you, operator, for the introduction. Before we begin, I would like to note that any comments made by management during this conference call may contain forward-looking statements regarding the operations and future results of OpGen, including its subsidiary Curetis and Ares Genetics.

I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K and Form 10-Q for

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.